期刊文献+

系统性红斑狼疮患者淋巴细胞共刺激分子异常表达的研究 被引量:1

Investigation of costimulatory molecules of lymphocytes in systemic erythematosus lupus (SLE) patients
原文传递
导出
摘要 目的探讨系统性红斑狼疮(SLE)患者淋巴细胞共刺激分子的表达及意义。方法采用流式细胞术检测SLE患者淋巴细胞CD28、CTLA-4、CD80和CD86的表达,并与对照组比较。结果与健康对照者相比较,SLE患者CD3^+细胞增加(P〈0.05),CD3^+CD4^+细胞降低(P〈0.05),CD3^+CD8^+细胞升高(P〈0.05),CD4/CD8比例明显倒置(P〈0.01),CD28表达降低,CTLA-4升高,CD86的表达显著高于正常人(P〈0.01),CD80在SLE患者CD19^+B细胞上的表达与正常人无异(P〉0.05)。结论T细胞亚群改变及T、B淋巴细胞共刺激分子CD28、CTLA-4和CD86在SLE发病机制中起重要作用。 Objective To investigate the roles of lymphocytes costimulatory molecules in systemic erythematosus lupus (SLE). Methods CD28, CTLA-4, CD80 and CD86 in lymphocytes in peripheral blood were detected with flow cytometry. Results T lymphocytes subsets changed in patients with SLE. Compared with healthy control, SLE patients have higher percentage of lymphocytes expressing CTLA-4, CD86, lower percentage of lymphocytes expressing CD28 and that of CD80 didn' t changed. Conclusion The changes of T lymphocyte subsets and lymphocyte costimulatory molecules CD28, CTLA-4 and CD86 may have roles in the development of SLE.
出处 《国际免疫学杂志》 CAS 2008年第1期5-7,共3页 International Journal of Immunology
基金 黑龙江省普通高等学校骨干教师创新能力自助计划项目(1054G062)
关键词 红斑狼疮 系统性 共刺激分子 Lupus erythematosus,Systemic Costimulatory molecules
  • 相关文献

参考文献15

  • 1Vila LM, Molina MJ, Mayor AM, et al. Clinical and prognostic value of autoantibodies in Puerto Ricans with systemic lupus erythematosus. Lupus, 2006, 15(12) :892-898.
  • 2Manzotti CN, Liu MK, Burke F, et al. Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86. Eur J Immunol, 2006, 36(6):1413-1422.
  • 3Tokunaga M, Fujii K, Saito K, et al. Down-regulation of CD40 and CD80 on B ceils in patients with life-threatening systemic lupus erythematosus after successful treatment with fituximab. Rheumatology, 2005, 44(2) :176-182.
  • 4Hueber A J, Matzkies FG, Rahmeh M, et al. CTLA-4 lacking the cytoplasmic domain costimulates IL-2 production in T-cell hybridomas. Immunol Cell Biol, 2006, 84( 1 ) :51-58.
  • 5Sandstrom K, Xu Z, Forsberg G, et al. Inhibition of the CD28CD80 co-stimulation signal by a CD28-binding affibody ligand developed by combinatorial protein engineering. Protein Eng, 2003, 16 (9) :691-697.
  • 6Pawlak E, Kochanowska IE, Frydecka I, et al. The soluble CTLA4 receptor: a new marker in autoimmune diseases. Arch Immunol Ther Exp, 2005, 53:336-341.
  • 7Wang H, Xu J, Ji X, et al. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus. Cell Immunol, 2005, 235(2) :117-121.
  • 8Holdenrieder S, Eichhorn P, Beuers U, et al. Nucleosomal DNA fragments in autoimmune diseases. Ann N Y Acad Sci, 2006, 1075:318-327.
  • 9Collins M, Ling V, Carreno BM. The B7 family of immune-regulatory ligands. Genome Biol, 2005, 6(6) :223.
  • 10Manzotti CN, Liu MK, Burke F, et al. Integration of CD28 and CTLA4 function results in differential responses of T cells to CD80 and CD86. Eur J Immunol, 2006, 36(6):1413-1422.

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部